Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases.

[1]  D. Marcus,et al.  Vitreous and aqueous penetration of orally administered gatifloxacin in humans. , 2004, Archives of ophthalmology.

[2]  W. Mieler,et al.  Vitreous and aqueous penetration of orally administered gatifloxacin in humans. , 2004 .

[3]  H. Flynn,et al.  Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes. , 2002, Ophthalmology.

[4]  E. Romanowski,et al.  Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. , 2002, American journal of ophthalmology.

[5]  D. Leaming.  Practice styles and preferences of ASCRS members—2000 survey , 2001, Journal of cataract and refractive surgery.

[6]  Y. Gordon,et al.  Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? , 2001, American journal of ophthalmology.

[7]  G. Alexandrakis,et al.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. , 2000, Ophthalmology.

[8]  E. Kurt,et al.  Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes. , 2000, International journal of pharmaceutics.

[9]  A. Anand,et al.  Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. , 2000, Indian journal of ophthalmology.

[10]  M. Shapiro,et al.  Aqueous and vitreous penetration of levofloxacin after oral administration. , 1999, Ophthalmology.

[11]  T. Das,et al.  Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. , 1999, American journal of ophthalmology.

[12]  T. Das,et al.  Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group. , 1999, American journal of ophthalmology.

[13]  J. Baum,et al.  Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review , 1999 .

[14]  O. Cars,et al.  Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin. , 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  H. Flynn,et al.  Delayed-onset endophthalmitis associated with conjunctival filtering blebs. , 1997, Ophthalmology.

[16]  D. Roth,et al.  Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy. , 1997, Survey of ophthalmology.

[17]  Joel M. Caplan,et al.  The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. , 1997, Ophthalmology.

[18]  S. Wisniewski,et al.  Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. , 1996, American journal of ophthalmology.

[19]  M. Sebag,et al.  The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. , 1993, American journal of ophthalmology.

[20]  J. Menikoff,et al.  Prophylaxis of endophthalmitis with topical povidone-iodine. , 1991, Ophthalmology.

[21]  S. Masket,et al.  Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. , 2002, Ophthalmology.

[22]  M. Durand.  Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. , 1997, American journal of ophthalmology.

[23]  Jennifer I. Lim,et al.  Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study , 1996 .

[24]  D. Leaming.  Practice styles and preferences of ASCRS members--1991 survey. American Society of Cataract and Refractive Surgery. , 1992, Journal of cataract and refractive surgery.